Summary & Overview
CPT 87506: Multiplex Nucleic Acid Test for Gastrointestinal Pathogens
CPT code 87506 represents a multiplex nucleic acid test that detects six to eleven gastrointestinal pathogens or subtypes responsible for infectious diarrhea, using methods such as multiplex reverse transcription and amplified probe techniques. This testing modality matters nationally because rapid, multiplex molecular diagnostics improve pathogen identification, inform infection control, and guide appropriate clinical management, reducing complications and unnecessary antibiotic use.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how CPT code 87506 is used in clinical practice, typical sites of service, and the clinical context for ordering multiplex gastrointestinal pathogen panels. The publication also summarizes common billing considerations and benchmarks where available, highlights relevant policy updates affecting laboratory molecular diagnostics reimbursement, and outlines implications for coding workflows and laboratory operations.
The content is intended for national audiences including laboratory managers, coding professionals, and policy analysts seeking clarity on clinical purpose, payer coverage context, and operational considerations for use of CPT code 87506 in molecular gastrointestinal pathogen testing.
Billing Code Overview
CPT code 87506 describes a laboratory test that detects six to eleven gastrointestinal pathogens or subtypes using nucleic acid detection methods, which may include multiplex reverse transcription and multiplex amplified probe techniques. The assay targets pathogens such as Clostridium difficile, Escherichia coli, Salmonella, Shigella, norovirus, and Giardia that cause infectious gastroenteritis.
-
Service type: Molecular multiplex nucleic acid detection assay for gastrointestinal pathogens
-
Typical site of service: Clinical laboratory or hospital laboratory; specimens are commonly collected in outpatient clinics, emergency departments, or inpatient settings and processed in a laboratory
Clinical & Coding Specifications
Clinical Context
A 38-year-old outpatient presents to an urgent care clinic with acute-onset watery diarrhea, abdominal cramping, low-grade fever, and occasional vomiting for 48 hours after dining at a local restaurant. The clinician collects a stool specimen and orders a multiplex gastrointestinal pathogen nucleic acid panel to rapidly identify bacterial, viral, and parasitic causes (for example, Clostridioides difficile, enteric E. coli, Salmonella, Shigella, norovirus, Giardia). The specimen is transported to an on-site or reference molecular diagnostics laboratory. A laboratory technologist performs the test using nucleic acid detection methods (multiplex RT-PCR and amplified probe techniques) that detect six to eleven target organisms or subtypes. Results are typically returned within hours to a day to guide infection control, public health reporting, and targeted therapy decisions. Typical sites of service include hospital outpatient laboratories, independent clinical laboratories, urgent care clinics with specimen collection, and reference laboratories. Common clinical workflow steps: specimen collection, accessioning, nucleic acid extraction/amplification, multiplex detection, result validation and reporting, and inclusion of a technical component and, if applicable, a professional interpretation component.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When a physician interprets or consults on the test result separate from the laboratory's technical performance |
TC | Technical component | When billing only the laboratory's technical portion (instrumentation, reagents, technologist time) |
90 | Reference (outside) laboratory | When the specimen is sent to an outside reference laboratory for testing |
91 | Repeat clinical diagnostic laboratory test | When the same test is repeated on the same day on the same specimen or patient for confirmation |
59 | Distinct procedural service | When reporting this test in addition to another unrelated test on the same day that might be bundled |
26 | Professional component | When a pathologist or laboratory physician provides interpretation (duplicate listed intentionally per CMS common use) |
52 | Reduced services | When the laboratory performs a reduced or partial version of the procedure |
53 | Discontinued procedure | When testing is started but discontinued due to pre-analytic or specimen issues |
90 | Reference laboratory (alternate usage) | When the billing entity indicates testing was performed by another lab (alternate common billing use) |
91 | Repeat test (alternate usage) | When a repeat assay is ordered for quality control or verification |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Pathology & Laboratory Medicine | Clinical laboratory directors and pathologists overseeing test interpretation |
| 207R00000X | Diagnostic Laboratory | Clinical laboratory technologists and managers performing testing |
| 208000000X | Infectious Disease | Infectious disease specialists who order and interpret results for patient management |
| 207L00000X | Clinical Microbiology | Specialists in microbiology responsible for assay validation and oversight |
| 207K00000X | Clinical Chemistry | Laboratory specialists involved when integrating molecular results with other lab data |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
A09 | Infectious gastroenteritis and colitis, unspecified | Common presenting diagnosis for acute diarrheal illness prompting a multiplex stool PCR |
A04.7 | Enterocolitis due to Clostridioides difficile | Specific indication for detecting C. difficile toxin genes via nucleic acid testing |
A02.0 | Salmonella enteritis | Bacterial enteric infection routinely detected by multiplex panels |
A04.3 | Shigellosis | Shigella species cause severe diarrhea and are targets on many panels |
A08.1 | Acute gastroenteritis due to norovirus | Viral cause of acute gastroenteritis included in many multiplex assays |
A07.1 | Giardiasis | Parasitic infection detected by some molecular gastrointestinal panels |
K52.9 | Noninfective gastroenteritis and colitis, unspecified | Used when clinical presentation is gastroenteritis but infectious etiology not confirmed |
R19.7 | Diarrhea, unspecified | Symptom code commonly used with laboratory testing orders |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
87471 | Infectious agent detection by nucleic acid (DNA or RNA); Clostridium difficile toxin B gene, amplified probe technique | May be ordered specifically when C. difficile is suspected; sometimes replaced by or complemented by multiplex panels |
88342 | Immunohistochemistry or special staining, per specimen; interpretation | Not routinely used with stool PCR but may be used for tissue samples in enteric disease workups |
87045 | Culture, bacterial, stool, routine, includes isolation and presumptive identification of isolates | Traditional stool bacterial culture often performed alongside molecular panels for isolate recovery and susceptibility testing |
88112 | Cytopathology, fluids, smears, except gynecologic; stool cytology (when indicated) | Rarely used but may be applied when evaluating parasitic or unusual cellular findings |
87449 | Infectious agent detection by nucleic acid (DNA or RNA); Norovirus, amplified probe technique | Individual pathogen assays that may be ordered if a targeted test is chosen instead of a multiplex panel |